Á¦6ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-09±³À°ÀÏÀÚ : 2021-05-09
±³À°Àå¼Ò : ¼Ò°øµ¿ ·Ôµ¥È£ÅÚ 2Ãþ Å©¸®½ºÅ»º¼·ë
±³À°ÁÖÁ¦ :
Á¦6ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑ°³¿øÀÇÇùÀÇȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ°³¿ø³»°úÀÇ»çȸ
´ã´çÀÚ : ÃÖ¿ì³ç
¿¬¶ôó : 02-582-9265
À̸ÞÀÏ :
kacc@kaccardio.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í »çÀü °³¿øÀÇ 2¸¸¿ø/ºÀÁ÷ÀÇ 2¸¸¿ø/Àü°øÀDZºÀÇ°ü°øº¸ÀÇ ¹«·á ÇöÀåµî·Ï ¾øÀ½
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 08:30~08:50 Hypertension step up - BP variability (HBPM, ABPM, cuffless BP monitoring), 2020 ISH °¡À̵å¶óÀÎreview À̹«¿ë(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 08:50~09:10 °í¿ë·® ½ºÅ¸Æ¾°ú ¹ÝÀÀÇÏÁö ¾Ê´Â ÀÌ»óÁöÁúÇ÷Áõ ȯÀÚ Ä¡·á-PCSK-9 ¾ïÁ¦Á¦¿Í Evinacumab (ANGPTL3 monoclonal antibody) È«¼øÁØ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 09:10~09:30 ½É¹æ¼¼µ¿ ȯÀÚ, °ú¿¬ 2021³â¿¡µµ Rate control¸¸ Çϸé ÃæºÐÇÒ±î? À̱âÈ«(Àü³²ÀÇ´ë)
Åä·Ð 05-09 Å©¸®½ºÅ»º¼·ë 09:30~09:40 Q & A ()
ÈÞ½Ä 05-09 Å©¸®½ºÅ»º¼·ë 09:55~10:10 coffee break ()
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 10:10~10:20 °¡½¿ÀÌ ¾ÆÇ ȯÀÚ, ¾ðÁ¦, ´©±¸¸¦ Àü¿ø½Ãų±î? ÀÌöȯ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 10:20~10:50 ¾ÈÁ¤Çü Çé½ÉÁõ(chronic coronary syndrome)ȯÀÚ, ÀûÀýÇÏ°Ô Ä¡·áÇϱâ ÀÌöȯ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 10:50~11:15 Coronary CT, coronary calcium score ¿Ã¹Ù¸¥ Çؼ®¹ý Á¶Àͼº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 11:15~11:40 ¼ö¼ú Àü consult, ÀÌ·¸°Ô ´ë´äÇÏÀÚ! ¹èÀåȯ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 11:40~12:00 ¼ö¼ú Àü, ÈÄ Ç×ÀÀ°íÁ¦ ÀÌ·¸°Ô Á¶ÀýÇÏÀÚ! ¹èÀåȯ(ÃæºÏÀÇ´ë)
½Ä»ç 05-09 Å©¸®½ºÅ»º¼·ë 12:00~13:00 Luncheon session ()
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 13:00~13:40 State of the Art : Çѱ¹ ½ÉÃÊÀ½ÆÄÀÇ ¾îÁ¦¿Í ¿À´Ã, ±×¸®°í ¹Ì·¡ Á¤³²½Ä(Çʸ޵𽺳»°ú)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 13:40~14:10 ´ç´¢º´ ȯÀÚ, ½ÉÇ÷°ü ÁúȯÀ» ¿¹¹æÇÏ·Á¸é ¾î¶»°Ô ÇØ¾ß ÇÒ±î? ±ÇÇõ»ó(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 14:10~14:40 GLP-1 agonist or SGLT2 antagonist, which should be considered 1st for the heart? ¹ÚÁ¤Çö(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 14:40~15:00 ´ç´¢º´ ȯÀÚ°¡ Àß °É¸®´Â ½ÉÇ÷°üÁúȯ ÃÑÁ¤¸® ½Å¼ºÈñ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 05-09 Å©¸®½ºÅ»º¼·ë 15:00~15:20 ´ç´¢º´¼º ¸»ÃÊ ½Å°æº´Áõ, ¾ðÁ¦ ÀǽÉÇÏ°í ¾î¶»°Ô Ä¡·áÇϳª? ±èÁ¾È(¼¼Á¾º´¿ø)
Åä·Ð 05-09 Å©¸®½ºÅ»º¼·ë 15:20~15:40 Q & A ()